Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Launched by SHANGHAI 6TH PEOPLE'S HOSPITAL · Nov 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to predict how difficult it might be to perform a specific type of thyroid surgery called transoral and submental thyroidectomy (TOaST) in patients with differentiated thyroid cancer. The researchers want to identify certain factors before surgery that could indicate whether the procedure will be easy or challenging. By doing this, they hope to create a tool that can help doctors better prepare for the surgery and meet patients' cosmetic expectations.
To participate in this trial, patients must have a diagnosis of differentiated thyroid cancer with tumors that are no larger than 4 cm and no signs of cancer spread to the lymph nodes or other parts of the body. Additionally, the trial is looking for patients who have had certain previous surgeries on their thyroid and lymph nodes. Participants can expect to be part of a study that aims to improve surgical outcomes and patient satisfaction. If you're considering this option, it's important to know that there are specific criteria that must be met to join, which helps ensure safety and effectiveness in the research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
- • Absence of suspicious lateral lymph nodes or distant metastases
- • Participants with high cosmetic expectations
- • Participants who underwent total thyroidectomy and central lymph node dissection.
- Exclusion Criteria:
- • Participants with fusion or fixation of lymph nodes in the neck
- • Participants with history of neck surgery or radiation
- • Participants with vocal fold fixation by preoperative fibrolaryngoscope
- • Participants with preoperative examination suggestive of extrathyroidal invasion
- • Participants with a significantly restricted neck
About Shanghai 6th People's Hospital
Shanghai 6th People's Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, striving to enhance patient outcomes and contribute to medical knowledge. With a dedicated team of experienced researchers and clinicians, Shanghai 6th People's Hospital emphasizes rigorous scientific methodology and ethical standards, ensuring that all trials are conducted with the utmost integrity and patient safety in mind. Through collaboration with various stakeholders, the hospital aims to bridge the gap between clinical research and real-world application, ultimately improving healthcare delivery both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Ling Zhan, Doctor
Principal Investigator
Shanghai 6th People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported